title: [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
abstract: In a sample of 35 patients with a diagnosis of panic disorder or agoraphobia with panic attacks according DSM III criteria, the authors found 8 patients (23%) with obsessive compulsive symptoms. This subgroup and 7 patients without obsessive compulsive symptoms were treated with fluvoxamine, a selective serotonin uptake inhibitor in an 8 weeks open study (2 weeks wash out, 6 weeks treatment). At the end of the study, a dramatic reduction of anxiety was found in different rating scales. Ten patients improved and no panic attack was noted: 7 in the group with obsessive compulsive symptoms (N = 8) and 3 in the group without obsessive compulsive symptoms (N = 7). Interest of fluvoxamine in panic patients with obsessive compulsive symptoms who do not respond to common antipanic medication is suggested. Controlled studies are necessary to confirm these first results.
authors.affiliation: Unité de Psychopathologie et Alcoologie, C.H.U. de Lille, Hôpital de la Charité.
authors.forename: D
authors.initials: D
authors.lastname: Servant
authors.forename: D
authors.initials: D
authors.lastname: Bailly
authors.forename: H
authors.initials: H
authors.lastname: Le Seac'h
authors.forename: P J
authors.initials: PJ
authors.lastname: Parquet
mesh_terms: D000328:Adult; D000379:Agoraphobia / Q000150:complications / Q000188:drug therapy*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D016666:Fluvoxamine; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000188:drug therapy*; D010091:Oximes / Q000627:therapeutic use*; D010200:Panic / Q000187:drug effects*
chemical_list: D000928:Antidepressive Agents; D010091:Oximes; D016666:Fluvoxamine
vernacular_title: Symptômes obsessionnels-compulsifs associés au trouble panique. Facteur prédictif d'une bonne réponse thérapeutique à la fluvoxamine.